Baruch Future Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Hinge Bio is a biotechnology company developing next-generation therapeutics based on its GEM-DIMER platform, aimed at improving efficacy and reducing resistance and side effects.
BiotechHealthtechBurlingame, US
Daniel J. Capon(Director)Carin M. Rollins(Executive Officer, Director)Harold E. Selick, PhD(Executive Officer, Director)Miriam Siekevitz(Executive Officer)Malcolm L. Gefter(Director)William D. Unger(Director)
Co-investorsPoint72InVivium CapitalAgent CapitalRidgeback Capital
Prolific Machines licenses an optogenetics platform that adds light-based control to cell line development and GMP biomanufacturing, letting biopharma teams retrofit existing bioreactors and hosts to raise titers and manufacture complex molecule formats.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechEmeryville, US
Maximilian HörnerMax Huisman(Chief Technology Officer & Co-Founder)inDeniz Kent(Chief Executive Officer & Co-Founder)inDeniz Kent, Ph.D.(Founder)inDeclan Jones(Founder)inShahram Misaghi
Co-investorsBreakthrough Energy VenturesDarco CapitalMayfield FundSolari CapitalTet Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.